Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.
Conditions
- Prostatic Neoplasms, Castration-Resistant
Interventions
- DRUG: Xtandi
- DRUG: Zytiga® (Abiraterone Acetate)
- RADIATION: SBRT
Sponsor
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
Collaborators